Wait to Buy the Pfizer Selloff

Why investors should wait before buying the Pfizer dip

Digital Content Manager
Jan 3, 2023 at 10:03 AM
facebook twitter linkedin

While the broader market is kicking off the new year on a high note, Pfizer Inc. (NYSE:PFE) is clinging close to breakeven. Last seen down less than 0.3% to trade at $51.08, the equity's 10-day moving average has reemerged as pressure, while a familiar ceiling at the $55 mark stopped the stock's fourth-quarter rally dead in its tracks. Investors might want to wait out buying the dip, however, as January tends to be a historically bearish month for PFE. 

This is per data from Schaeffer's Quantitative Analyst Rocky White, who complied a list of the 25 worst performing S&P 500 (SPX) stocks during the month. According to this list, seven of the past 10 Januaries have resulted in losses for Pfizer stock, which also averaged a 1.8% monthly decline during that time period, making it the second worst pharmaceutical stock on the list. From its current perch, a similar drop would put PFE at roughly $52.

A round of downgrades could be in the cards. Of the 10 analysts in coverage, seven call it a "strong buy." Plus, the 12-month consensus price target of $55.49 is an 8.1% premium to current levels. 

Now could be a good time to speculate on more downside for PFE with options. This is because the security sports a Schaeffer's Volatility Index (SVI) of 23%, which stands higher than just 4% of readings from the past year. In other words, options players are pricing in relatively low volatility expectations at the moment. 


Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!